Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Dow
Merck
Fish and Richardson
Accenture
Federal Trade Commission
Cerilliant
Chubb

Generated: June 25, 2018

DrugPatentWatch Database Preview

Hetero Labs Ltd Iii Company Profile

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?

HETERO LABS LTD III has twenty-eight approved drugs.

There are four tentative approvals on HETERO LABS LTD III drugs.

Summary for Hetero Labs Ltd Iii
US Patents:0
Tradenames:24
Ingredients:24
NDAs:28

Drugs and US Patents for Hetero Labs Ltd Iii

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd Iii SIMVASTATIN simvastatin TABLET;ORAL 200895-001 Nov 25, 2014 AB RX No No ➤ Sign Up ➤ Sign Up
Hetero Labs Ltd Iii OSELTAMIVIR PHOSPHATE oseltamivir phosphate CAPSULE;ORAL 209438-003 Feb 23, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Hetero Labs Ltd Iii LEVETIRACETAM levetiracetam TABLET;ORAL 090515-001 Oct 8, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
Hetero Labs Ltd Iii STAVUDINE stavudine CAPSULE;ORAL 078957-002 Dec 29, 2008 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cantor Fitzgerald
Chinese Patent Office
Teva
Harvard Business School
Healthtrust
AstraZeneca
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.